CJC 1295


Image Description


Substance

Growth Hormone Releasing


Active Dosage

2mg/vial


Form

10 x 10iu


Category

Injectable


Classification

Peptide


Half Life

6-8 days


Dosage

50-100 mcg. / day


Acne

No


Water Retention

No


HBR

No


Aromatization

No


Hepatoxity

No


Description

CJC 1295 has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC 1295 shown potential to increase growth hormone and IGF-I secretion and e!ects, but it has been able to do so in very large amounts. CJC 1295 Stimulates Growth Hormone Secretion, and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to fat loss, and increased protein synthesis thereby promoting growth. CJC 1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a growth hormone releasing hormone (GHRH) analog. One of the advantages of CJC 1295 over traditional GHRH or rHGH is its ability to bioconjugate with serum albumin, thus increasing its half-life and therapeutic window. It accomplishes this by using protecting groups around the amino acids of GHRH typically susceptible to enzymatic degradation.

About Us

Founded in 2018, Odin Pharma is a sterile pharmacetuical company that manufactures and markets anabolics for the worldwide healthcare market.

Supplier Verification: www.check-odin.com

Our Contacts

Head Office:
Clementi, Singapore, Asia

Factory:
Queenstown, Singapore, Asia